Vinge has advised Procuritas Capital Investors VII (“Procuritas”) in connection with the acquisition of Parkman i Sverige AB (“Parkman”), a growing Swedish tech-enabled parking operator that provides parking management solutions. As part of the transaction, Indigo Management AS becomes a minority owner of the company.

Parkman is a Swedish company offering complete parking management solutions with a broad range of technical and operational services. The company serves a diverse portfolio of properties, including retail centres, offices and residential areas. 

Parkman reported revenues of 610 MSEK in 2024. The company employs approximately 85 full-time and 50 part-time employees.

Vinge’s team consisted of Jonas Johansson, Desirée Hagenfeldt, Linus Adolfsson and Ian Linde (M&A), Helena Göransson, Arvid Weimers, Calle Tengwall Pagels, Ida Appelgren, William Carlberg Johansson (Banking and Finance), Christoffer Nordin, Gabriel Pålsson and Filippa Eriksson (Corporate Commercial), Simon Gille-Johnson and Wilma Hellman (Real Estate), William Karo Persson (Employment & Benefits), Fredrik Hellström and Hilda Ivarsson (Competition) and Filippa Bergkvist (Transaction Support).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026